We are live on
!
Find out more
BNP Paribas Asset Management Portfolio holdings
AUM
$86.1B
1-Year Est. Return
29.11%
This Fund
S&P 500
This Quarter
Est. Return
-2.17%
1 Year Est. Return
+29.11%
3 Year Est. Return
+87.64%
5 Year Est. Return
+102.48%
10 Year Est. Return
+408.22%
AUM
$86.1B
AUM Growth
-$1.05B
(-1.2%)
Cap. Flow
+$4.86B
Cap. Flow
% of AUM
5.64%
Top 10 Holdings %
Top 10 Hldgs %
27.63%
Holding
2,366
New
101
Increased
1,396
Reduced
686
Closed
108
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$1.43B |
| 2 |
TotalEnergies
TTE
|
+$626M |
| 3 |
Deutsche Bank
DB
|
+$326M |
| 4 |
Stellantis
STLA
|
+$263M |
| 5 |
Broadcom
AVGO
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ciena
CIEN
|
+$291M |
| 2 |
Apple
AAPL
|
+$262M |
| 3 |
Amazon
AMZN
|
+$219M |
| 4 |
Tesla
TSLA
|
+$205M |
| 5 |
Meta Platforms (Facebook)
META
|
+$197M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.22% |
| 2 | Healthcare | 13.97% |
| 3 | Financials | 10.51% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CSR
1751
Centerspace
CSR
$936M
| $38.7K | ﹤0.01% |
673
+150
| +29% | +$9.43K |
|
1752
Acadia Pharmaceuticals
ACAD
$4.25B
| $38.5K | ﹤0.01% |
1,730
+309
| +22% | +$7.38K |
|
1753
Agilysys
AGYS
$2.78B
| $38.3K | ﹤0.01% |
539
+151
| +39% | +$13.1K |
|
1754
Lindsay Corp
LNN
$1.16B
| $38.3K | ﹤0.01% |
322
+99
| +44% | +$12.6K |
|
1755
Unitil
UTL
$1,000M
| $38.3K | ﹤0.01% |
733
+219
| +43% | +$11.2K |
|
1756
Verra Mobility
VRRM
$615M
| $38.3K | ﹤0.01% |
2,678
+548
| +26% | +$10K |
|
1757
Columbia Sportswear
COLM
$3.19B
| $38.3K | ﹤0.01% |
698
+235
| +51% | +$13.5K |
|
1758
Synaptics
SYNA
$4.41B
| $38K | ﹤0.01% |
542
+152
| +39% | +$12.3K |
|
1759
Enova International
ENVA
$5.91B
| $37.9K | ﹤0.01% |
279
+37
| +15% | +$5.51K |
|
1760
Atlanta Braves Holdings Series B
BATRK
$3.23B
| $37.7K | ﹤0.01% |
882
+299
| +51% | +$12.4K |
|
1761
Douglas Dynamics
PLOW
$1.07B
| $37.5K | ﹤0.01% |
891
+332
| +59% | +$13.4K |
|
1762
Amprius Technologies
AMPX
$1.31B
| $37.5K | ﹤0.01% |
2,224
+604
| +37% | +$7.87K |
|
1763
FB Financial Corp
FBK
$2.95B
| $37.4K | ﹤0.01% |
720
+115
| +19% | +$6.46K |
|
1764
BGC Group
BGC
$5.58B
| $37.4K | ﹤0.01% |
3,820
-4
| -0.1% | -$37 |
|
1765
Omnicell
OMCL
$1.86B
| $37K | ﹤0.01% |
1,107
+334
| +43% | +$14K |
|
1766
Warby Parker
WRBY
$3.01B
| $36.9K | ﹤0.01% |
1,753
+413
| +31% | +$10.2K |
|
|
OPTU
1767
Optimum Communications Inc
OPTU
$316M
| $36.7K | ﹤0.01% |
28,200
-4,012
| -12% | -$6.31K |
|
|
BWIN
1768
Baldwin Insurance Group
BWIN
$2.58B
| $36.6K | ﹤0.01% |
1,668
+509
| +44% | +$11K |
|
1769
Simmons First National
SFNC
$3.35B
| $36.5K | ﹤0.01% |
1,875
+435
| +30% | +$8.68K |
|
1770
Beam Therapeutics
BEAM
$2.58B
| $36.3K | ﹤0.01% |
1,524
+372
| +32% | +$10.3K |
|
|
DMC
1771
Del Monte Corp
DMC
$1.35B
| $36.3K | ﹤0.01% |
902
+348
| +63% | +$13.9K |
|
1772
Silgan Holdings
SLGN
$4.91B
| $36.2K | ﹤0.01% |
934
+121
| +15% | +$5.31K |
|
1773
Kemper
KMPR
$1.7B
| $36.2K | ﹤0.01% |
1,185
+263
| +29% | +$9K |
|
1774
Addus HomeCare
ADUS
$2.14B
| $36K | ﹤0.01% |
384
+102
| +36% | +$10.8K |
|
1775
ACM Research
ACMR
$5.83B
| $35.9K | ﹤0.01% |
913
-470
| -34% | -$24.9K |
|
Similar funds
BNP Paribas Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, BNP Paribas Asset Management held 2,366 positions worth $86.1B, down 1.2% from $87.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
BNP Paribas Asset Management deployed $4.86B of net new capital in Q1 2026, opening 101 new positions and adding to 1,396 existing holdings. Its largest new stake was Viking Holdings: 1,864,036 shares worth $137M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Ciena, an estimated $291M trimmed.
- BNP Paribas Asset Management's largest Q1 2026 buy was Viking Holdings: 1,864,036 shares worth $137M.
- BNP Paribas Asset Management added most to AstraZeneca in Q1 2026, an estimated $1.43B increase.
- BNP Paribas Asset Management's biggest Q1 2026 reduction was Ciena, cutting an estimated $291M.
- BNP Paribas Asset Management fully exited Exact Sciences in Q1 2026, selling an estimated $35.9M.
- BNP Paribas Asset Management's ten largest holdings make up 28% of its $86.1B portfolio in Q1 2026.
- BNP Paribas Asset Management opened 101 new positions and closed 108 in Q1 2026.
- BNP Paribas Asset Management's portfolio value fell 1.2% quarter-over-quarter to $86.1B.
Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.